Måndag 15 December | 20:48:19 Europe / Stockholm

Crh

Kalender

Est. tid*
2026-11-05 08:00 Kvartalsrapport 2026-Q3
2026-08-10 08:00 Kvartalsrapport 2026-Q2
2026-05-06 08:00 Kvartalsrapport 2026-Q1
2026-02-27 08:00 Bokslutskommuniké 2025
2025-11-21 - X-dag kvartalsutdelning CRH 27.8166
2025-11-05 - Kvartalsrapport 2025-Q3
2025-08-22 - X-dag kvartalsutdelning CRH 27.339
2025-08-06 - Kvartalsrapport 2025-Q2
2025-05-23 - X-dag kvartalsutdelning CRH 27.394801
2025-05-08 - Årsstämma
2025-05-05 - Kvartalsrapport 2025-Q1
2025-03-14 - X-dag bonusutdelning CRH 28.560299
2025-02-26 - Bokslutskommuniké 2024
2024-11-22 - X-dag bonusutdelning CRH 27.621999
2024-11-07 - Kvartalsrapport 2024-Q3
2024-08-23 - X-dag bonusutdelning CRH 26.795
2024-08-08 - Kvartalsrapport 2024-Q2
2024-05-23 - X-dag bonusutdelning CRH 27.230981
2024-05-10 - Kvartalsrapport 2024-Q1
2024-04-25 - Årsstämma
2024-03-14 - X-dag bonusutdelning CRH 0
2024-02-29 - Bokslutskommuniké 2023
2023-12-14 - X-dag halvårsutdelning CRH 84.9204
2023-10-19 - X-dag halvårsutdelning CRH 20.317499
2023-06-08 - Extra Bolagsstämma
2023-04-27 - Årsstämma
2023-03-16 - X-dag halvårsutdelning CRH 80.39
2022-09-08 - X-dag halvårsutdelning CRH 21.8808
2022-04-28 - Årsstämma
2022-03-10 - X-dag halvårsutdelning CRH 75.205201
2021-09-09 - X-dag halvårsutdelning CRH 16.804881
2021-04-29 - Årsstämma
2021-03-18 - X-dag halvårsutdelning CRH 66.560102
2021-03-04 - Bokslutskommuniké 2020
2021-02-09 - Extra Bolagsstämma
2020-09-03 - X-dag halvårsutdelning CRH 17.148675
2020-08-20 - Kvartalsrapport 2020-Q2
2020-04-23 - Årsstämma
2020-03-12 - X-dag halvårsutdelning CRH 55.137223
2019-09-05 - X-dag halvårsutdelning CRH 17.78734
2019-03-14 - X-dag halvårsutdelning CRH 45.241478
2018-09-06 - X-dag halvårsutdelning CRH 17.481416
2018-03-08 - X-dag halvårsutdelning CRH 42.716447
2017-09-07 - X-dag halvårsutdelning CRH 17.146
2017-03-09 - X-dag halvårsutdelning CRH 39.239278
2016-09-08 - X-dag halvårsutdelning CRH 16.734236
2016-03-10 - X-dag halvårsutdelning CRH 34.109417
2015-09-10 - X-dag halvårsutdelning CRH 13.278782
2015-03-05 - X-dag halvårsutdelning CRH 31.9396
2014-08-27 - X-dag halvårsutdelning CRH 14.726925
2014-03-05 - X-dag halvårsutdelning CRH 36.181331
2013-08-28 - X-dag halvårsutdelning CRH 15.672313
2013-03-06 - X-dag halvårsutdelning CRH 37.321019
2012-08-22 - X-dag halvårsutdelning CRH 14.896293
2012-03-07 - X-dag halvårsutdelning CRH 35.745689
2011-08-24 - X-dag halvårsutdelning CRH 16.194899
2011-03-09 - X-dag halvårsutdelning CRH 40.42136
2010-09-01 - X-dag halvårsutdelning CRH 16.2985
2010-03-10 - X-dag halvårsutdelning CRH 38.0732
2009-09-02 - X-dag halvårsutdelning CRH 16.651849
2009-03-11 - X-dag halvårsutdelning CRH 43.485099
2008-09-03 - X-dag halvårsutdelning CRH 16.665475
2008-03-12 - X-dag halvårsutdelning CRH 45.873002
2007-09-05 - X-dag halvårsutdelning CRH 13.504
2007-03-14 - X-dag halvårsutdelning CRH 26.299349
2005-03-09 - X-dag halvårsutdelning CRH 16.12026
2004-09-08 - X-dag halvårsutdelning CRH 6.53904

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2023-11-22 08:35:36

DUBLIN, Ireland, Nov. 22, 2023 (GLOBE NEWSWIRE) -- CRH plc, the leading provider of building materials solutions, is pleased to announce that it has reached an agreement to divest its lime operations in Europe (the "Business") to SigmaRoc plc for a total consideration of c.$1.1 billion. The transaction is subject to customary conditions and regulatory approvals.

The Business comprises 16 operating locations with leading market positions across Ireland, the UK, Germany, Czech Republic and Poland. The combined Business generated sales of c.$610 million and EBITDA of c.$137 million in 2022.

The transaction is structured in three phases, the first of which is expected to complete in early 2024 comprising the Group's lime operations in Germany, Czech Republic and Ireland. The remaining phases, consisting of operations in the UK and Poland, are expected to complete in 2024.

Albert Manifold, Chief Executive of CRH, said: "The decision to divest at an attractive valuation follows a comprehensive review of the Business and demonstrates CRH's active approach to portfolio management. The proceeds from the divestment will provide us with significant additional capital allocation opportunities to deliver further growth and value creation for our shareholders."

Contact CRH at Dublin 404 1000 (+353 1 404 1000)

Albert ManifoldChief Executive
Jim MinternChief Financial Officer
Frank HeisterkampDirector of Capital Markets & ESG
Tom HolmesHead of Investor Relations

About CRH
CRH (NYSE: CRH, LSE: CRH) is the leading provider of building materials solutions that build, connect and improve our world. Employing c.75,800 people at c.3,160 operating locations in 29 countries, CRH has market leadership positions in both North America and Europe. As the essential partner for road and critical utility infrastructure, commercial building projects and outdoor living solutions, CRH's unique offering of materials, products and value-added services helps to deliver a more resilient and sustainable built environment. The company is ranked among sector leaders by Environmental, Social and Governance (ESG) rating agencies. A Fortune 500 company, CRH's shares are listed on the NYSE and LSE.

Registered Office: No 12965. Registered Office: 42 Fitzwilliam Square, Dublin 2, R02 R279, Ireland

Forward-Looking Statements

This document contains statements that are, or may be deemed to be forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995.

These forward-looking statements may generally, but not always, be identified by the use of words such as "will", "believe", "continues", "is expected to", or similar expressions. These forward-looking statements include all matters that are not historical facts or matters of fact at the date of this document.

This document contains statements that are, or may be deemed to be, forward-looking statements with respect to the financial condition, results of operations, business, viability and future performance of CRH and certain of the plans and objectives of CRH, including but not limited to statements regarding expectations for the anticipated timing and benefits of the divestment and plans and expectations regarding CRH's further growth and shareholder value creation.

Forward-looking statements are subject to risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future and/or are beyond CRH's control or precise estimate.

Such risks, uncertainties and other factors include, but are not limited to, economic and financial conditions, including market turbulence, high interest rates, inflation, price volatility and/or labour and materials shortages in various countries and regions where we operate; the pace of growth in the sectors in which we operate; demand for infrastructure, residential and non-residential construction and our products in our geographic markets; increased competition and its impact on prices; and increases in energy and/or raw materials costs. There are other important factors, risks and uncertainties that could cause actual outcomes and results to be materially different, including risks and uncertainties relating to CRH described under "Principal Risks and Uncertainties" in CRH's Report on Form 6-K regarding the results for the six-month period ended 30 June 2023, as filed with the US Securities and Exchange Commission (the "SEC"), as well as "Principal Risks and Uncertainties (Risk Factors)" in the Company's 2022 Annual Report on Form 20-F as filed with the SEC.

You are cautioned not to place undue reliance on any forward-looking statements. These forward-looking statements are made as of the date of this document. The Group expressly disclaims any obligation or undertaking to publicly update or revise these forward-looking statements other than as required by applicable law.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.